< Brochure Homepage | Faculty Index | Pathology Homepage



Email mlin36@jhmi.edu
Phone (410) 955-8363

Related Websites
Molecular Pathology


Ming-Tseh Lin, M.D., Ph.D.

Director of Molecular Diagnostics Lab
Primary Appointment in Pathology


My previous experience provides a unique perspective in Molecular Diagnostics, as I initially practiced as a hematologist and bone marrow transplant specialist. I am currently appointed as the Director of the Molecular Diagnostics Laboratory. My personal expertise is in the development and validation of new assays, including the clinical application of next generation sequencing (NGS) platform. We have validated the NGS platform for mutation detection of formalin-fixed paraffin-embedded neoplastic tissues in our CLIA-certified Molecular Diagnostics Laboratory. My research focuses on the association of single nucleotide polymorphisms with outcomes of hematopoietic cell transplantation in the past, and currently on the identification of cancer biomarkers. I also work on the design of novel tandem duplication PCR assays for the detection of minimal residual disease of FLT/ITD AML and the exploration of mechanisms for internal tandem duplication of the human genome.

Publications
http://www.ncbi.nlm.nih.gov/pubmed/?term=Ming-Tseh+Lin




Email mlin36@jhmi.edu
Phone (410) 955-8363

Related Websites
Molecular Pathology


Ming-Tseh Lin, M.D., Ph.D.

Director of Molecular Diagnostics Lab
Primary Appointment in Pathology


My previous experience provides a unique perspective in Molecular Diagnostics, as I initially practiced as a hematologist and bone marrow transplant specialist. I am currently appointed as the Director of the Molecular Diagnostics Laboratory. My personal expertise is in the development and validation of new assays, including the clinical application of next generation sequencing (NGS) platform. We have validated the NGS platform for mutation detection of formalin-fixed paraffin-embedded neoplastic tissues in our CLIA-certified Molecular Diagnostics Laboratory. My research focuses on the association of single nucleotide polymorphisms with outcomes of hematopoietic cell transplantation in the past, and currently on the identification of cancer biomarkers. I also work on the design of novel tandem duplication PCR assays for the detection of minimal residual disease of FLT/ITD AML and the exploration of mechanisms for internal tandem duplication of the human genome.

Publications
http://www.ncbi.nlm.nih.gov/pubmed/?term=Ming-Tseh+Lin


 


Copyright © 2017 Johns Hopkins University. All Rights Reserved